» Articles » PMID: 36149056

Consequences of PDGFRα Fibroblast Reduction in Adult Murine Hearts

Abstract

Fibroblasts produce the majority of collagen in the heart and are thought to regulate extracellular matrix (ECM) turnover. Although fibrosis accompanies many cardiac pathologies and is generally deleterious, the role of fibroblasts in maintaining the basal ECM network and in fibrosis in vivo is poorly understood. We genetically ablated fibroblasts in mice to evaluate the impact on homeostasis of adult ECM and cardiac function after injury. Fibroblast-ablated mice demonstrated a substantive reduction in cardiac fibroblasts, but fibrillar collagen and the ECM proteome were not overtly altered when evaluated by quantitative mass spectrometry and N-terminomics. However, the distribution and quantity of collagen VI, microfibrillar collagen that forms an open network with the basement membrane, was reduced. In fibroblast-ablated mice, cardiac function was better preserved following angiotensin II/phenylephrine (AngII/PE)-induced fibrosis and myocardial infarction (MI). Analysis of cardiomyocyte function demonstrated altered sarcomere shortening and slowed calcium decline in both uninjured and AngII/PE-infused fibroblast-ablated mice. After MI, the residual resident fibroblasts responded to injury, albeit with reduced proliferation and numbers immediately after injury. These results indicate that the adult mouse heart tolerates a significant degree of fibroblast loss with a potentially beneficial impact on cardiac function after injury. The cardioprotective effect of controlled fibroblast reduction may have therapeutic value in heart disease.

Citing Articles

Transcription Factor 21 Regulates Cardiac Myofibroblast Formation and Fibrosis.

Johansen A, Kasam R, Vagnozzi R, Lin S, Gomez-Arroyo J, Shittu A Circ Res. 2024; 136(1):44-58.

PMID: 39629593 PMC: 11740189. DOI: 10.1161/CIRCRESAHA.124.325527.


Rapid onset fibrotic remodeling and ventricular dysfunction induced by phenylephrine involve targeted reprogramming of myocyte and fibroblast transcriptomes.

Kimball T, Gromova T, Gehred N, Chapski D, Wang K, Vaseghi M bioRxiv. 2024; .

PMID: 39464022 PMC: 11507669. DOI: 10.1101/2024.10.11.617933.


Cardiac Fibroblasts regulate myocardium and coronary vasculature development via the collagen signaling pathway.

Deng Y, He Y, Xu J, He H, Zhang M, Li G bioRxiv. 2024; .

PMID: 39314489 PMC: 11418987. DOI: 10.1101/2024.09.11.612512.


Linking immune modulation to cardiac fibrosis.

Bengel F, Epstein J, Gropler R, Haberkorn U, Kramann R, Lavine K Nat Cardiovasc Res. 2024; 3(4):414-419.

PMID: 39196217 DOI: 10.1038/s44161-024-00459-3.


Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies.

Patrick R, Janbandhu V, Tallapragada V, Tan S, McKinna E, Contreras O Sci Adv. 2024; 10(25):eadk8501.

PMID: 38905342 PMC: 11192082. DOI: 10.1126/sciadv.adk8501.


References
1.
Factor S, Robinson T, Dominitz R, Cho S . Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture. A preliminary report. Am J Cardiovasc Pathol. 1987; 1(1):91-7. View

2.
Kong P, Christia P, Frangogiannis N . The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2013; 71(4):549-74. PMC: 3769482. DOI: 10.1007/s00018-013-1349-6. View

3.
Fortelny N, Yang S, Pavlidis P, Lange P, Overall C . Proteome TopFIND 3.0 with TopFINDer and PathFINDer: database and analysis tools for the association of protein termini to pre- and post-translational events. Nucleic Acids Res. 2014; 43(Database issue):D290-7. PMC: 4383881. DOI: 10.1093/nar/gku1012. View

4.
Ali S, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A . Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res. 2014; 115(7):625-35. DOI: 10.1161/CIRCRESAHA.115.303794. View

5.
Gourdie R, Dimmeler S, Kohl P . Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov. 2016; 15(9):620-638. PMC: 5152911. DOI: 10.1038/nrd.2016.89. View